基于细胞凋亡机制的抗肿瘤药物的研究是发现新型抗肿瘤药物的重要策略。该机制中与肿瘤发生和发展相关的有死亡受体、Bcl-2家族、IAP家族、MDM2蛋白等,该文对近年来以这些蛋白和受体为靶标的抗肿瘤药物研究进展进行综述。
It is one of the most important strategy to discover novel anti-tumour drugs based on apoptosis mechanism. This review will highlight recent advances on the design and development of novel anti-tumour drugs targeting the death receptors,Bcl-2 family proteins,inhibitor of apoptosis proteins and MDM2 protein in the apoptosis pathway.